StockData
AIM ImmunoTech Inc. logo

AIM ImmunoTech Inc. (AIM) stock

AIMNYSEBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 2/30
$0.14+0.01 (+3.82%)

Close on Nov 17, 2026Market cap $4.14MP/E –Yield –

AIM ImmunoTech market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

AIM ImmunoTech's market cap was $4.30M on Nov 11, 2026, against $4.20M a year earlier. Over the last 5 years it ranged from $1.59M to $50.82M, with a median of $18.71M.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$4.30M+37.9%
2025Dec 31, 2025$3.12M-73.1%
2024Dec 31, 2024$11.60M-45.9%
2023Dec 29, 2023$21.44M+43.9%
2022Dec 30, 2022$14.91M-66.1%
2021Dec 31, 2021$43.98M-39.6%
2020Dec 31, 2020$72.75M+2109.7%
2019Dec 31, 2019$3.29M-62.0%
2018Dec 31, 2018$8.67M-20.3%
2017Dec 29, 2017$10.88M-34.5%
2016Dec 30, 2016$16.61M-16.1%
2015Dec 31, 2015$19.81M-59.1%
2014Dec 31, 2014$48.43M+7.1%
2013Dec 31, 2013$45.23M+22.6%
2012Dec 31, 2012$36.88M+36.1%
2011Dec 30, 2011$27.11M–

More AIM ImmunoTech figures

See a number that looks wrong?